[1]
Muhamad Luthfi Asyhar, “Sodium–Glucose Cotransporter-2 (SGLT-2) Inhibitors for Slowing the Progression of Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials and Primary Studies”, the int. j. of med. science and health, vol. 48, no. 4, pp. 352–437, Jul. 2026, doi: 10.70070/7n0yfm95.